-
Takeda eyes up Shire
pharmatimes
July 19, 2018
Takeda has revealed that it is considering making a move on Shire to add ballast to its core therapeutic areas.
-
Shire turns down Takeda’s advances
pharmatimes
July 16, 2018
Shire has now confirmed that it has thus far rejected three merger proposals from Takeda, the last one being valued at around $44 billion.
-
Takeda ups its offer for Shire
pharmatimes
July 16, 2018
Takeda has put forward a new proposed bid for Shire, increasing the cash portion of the deal.
-
Takeda gets US nod for Shire buy
pharmatimes
July 11, 2018
Takeda says it has received unconditional clearance from the US Federal Trade Commission for the proposed acquisition of Shire.
-
Takeda to buy Shire for £46 billion
pharmatimes
July 09, 2018
Takeda is moving ahead with its quest to acquire UK-listed Shire, after the latter approved an offer equating to around £46 billion.
-
Takeda’s Osaka headquarters up for sale as drugmaker funds $62B Shire buyout
fiercepharma
July 06, 2018
It’s no secret that Takeda is taking on a huge debt load to make the $62 billion Shire acquisition happen. Now, it’s looking to fill some of the financial gap by selling its old headquarters in Osaka, Japan.
-
Takeda clinches $62B deal to drugmaker Shire
biospectrumasia
May 09, 2018
The final deal is approximately 46 percent cash and 54 percent stock, leaving Shire shareholders owning around half of the combined group.
-
Takeda bids on Shire for $64-billion
biospectrumasia
April 28, 2018
The companies also received an extension from UK regulators until May 8 for Takeda to make a firm offer
-
Takeda’s hard-won Shire deal and Nektar I-O pact; Daiichi’s DMD flop
fiercepharma
April 28, 2018
It took five tries, but Takeda has finally reached a preliminary buyout deal for Shire. Investors don't seem all that keen on it...
-
Shire recommends Takeda’s £46bn bid
pharmaphorum
April 26, 2018
It looks like the biggest pharma merger of the year so far is on, after Shire recommended shareholders accept a bid from Takeda worth around £46 billion.